Corbus Pharmaceuticalsの空売り状況は、投資家がCorbus Pharmaceuticalsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Corbus Pharmaceuticals (NASDAQ:CRBP) 株価情報, 空売り情報

Corbus Pharmaceuticals

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Corbus Pharmaceuticals Holdings, Inc. - Common Stock

Corbus Pharmaceuticals Holdings Inc

CIBC analyst Robert Catellier upgrades TC Energy (TSX:<a class="ticker" href="https://www.benzinga.com/stock/TRP#TSX">TRP</a>) from Neutral to Outperformer and raises the price target from C$71 to C$76.

News

Upgrades

Price Target

Analyst Ratings

TSX:TRP

CIBC Upgrades TC Energy to Outperformer, Raises Price Target to C$76

In the current session, the stock is trading at $29.32, after a 1.03% spike. Over the past month, TechnipFMC Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FTI#NYSE">FTI</a>) stock increased by 17.31%, and in the past year, by 11.97%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1746201648_0.png" alt="Past Year Chart" />

<h3>TechnipFMC P/E Ratio Analysis in Relation to Industry Peers</h3>
The P/E ratio is used by long-term shareholders to assess the company's market performance against aggregate market data, historical earnings, and the industry at large. A lower P/E could indicate that shareholders do not expect the stock to perform better in the future or it could mean that the company is undervalued. 
Compared to the aggregate P/E ratio of the 18.19 in the Energy Equipment &amp; Services industry, TechnipFMC Inc. has a lower P/E ratio of 15.35. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1746201648_1.png" alt="Guage" />

In summary, while the price-to-earnings ratio is a valuable tool for investors to evaluate a company's market performance, it should be used with caution. A low P/E ratio can be an indication of undervaluation, but it can also suggest weak growth prospects or financial instability. Moreover, the P/E ratio is just one of many metrics that investors should consider when making investment decisions, and it should be evaluated alongside other financial ratios, industry trends, and qualitative factors. By taking a comprehensive approach to analyzing a company's financial health, investors can make well-informed decisions that are more likely to lead to successful outcomes.

Intraday Update

Markets

A Look Into TechnipFMC Inc's Price Over Earnings

Financial giants have made a conspicuous bearish move on Qualcomm. Our analysis of options history for Qualcomm (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QCOM#NASDAQ">QCOM</a>) revealed 17 unusual trades.
Delving into the details, we found 35% of traders were bullish, while 58% showed bearish tendencies. Out of all the trades we spotted, 8 were puts, with a value of $686,931, and 9 were calls, valued at $450,715.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $90.0 to $190.0 for Qualcomm over the last 3 months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Qualcomm's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Qualcomm's whale activity within a strike price range from $90.0 to $190.0 in the last 30 days. 
<h3>Qualcomm 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746201647_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$52.7</td>
<td>$51.9</td>
<td>$51.9</td>
<td>$190.00</td>
<td>$311.4K</td>
<td>1</td>
<td align="right">60</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>03/20/26</td>
<td>$6.75</td>
<td>$6.65</td>
<td>$6.75</td>
<td>$110.00</td>
<td>$109.3K</td>
<td>375</td>
<td align="right">194</td>
</tr>
<tr>
<td>QCOM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$31.25</td>
<td>$30.9</td>
<td>$30.88</td>
<td>$170.00</td>
<td>$77.2K</td>
<td>103</td>
<td align="right">25</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$9.4</td>
<td>$9.25</td>
<td>$9.3</td>
<td>$135.00</td>
<td>$63.2K</td>
<td>663</td>
<td align="right">355</td>
</tr>
<tr>
<td>QCOM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$4.1</td>
<td>$4.05</td>
<td>$4.05</td>
<td>$180.00</td>
<td>$60.7K</td>
<td>1.6K</td>
<td align="right">150</td>
</tr>
</tbody>
</table>

<h3>About Qualcomm</h3>
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G, 4G, and 5G networks. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones, as well as chips into automotive and Internet of Things markets.
Having examined the options trading patterns of Qualcomm, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Present Market Standing of Qualcomm</h3>
<ul>
<li>With a trading volume of 4,967,270, the price of QCOM is up by 4.02%, reaching $140.65.</li>
<li>Current RSI values indicate that the stock is may be approaching overbought.</li>
<li>Next earnings report is scheduled for 89 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Qualcomm</h3>
Over the past month, 5 industry analysts have shared their insights on this stock, proposing an average target price of $168.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from JP Morgan downgraded its rating to Overweight, setting a price target of $185. 
&#x2A; An analyst from Loop Capital has decided to maintain their Hold rating on Qualcomm, which currently sits at a price target of $155. 
&#x2A; An analyst from Susquehanna has decided to maintain their Positive rating on Qualcomm, which currently sits at a price target of $190. 
&#x2A; Consistent in their evaluation, an analyst from Cantor Fitzgerald keeps a Neutral rating on Qualcomm with a target price of $150. 
&#x2A; Consistent in their evaluation, an analyst from TD Cowen keeps a Buy rating on Qualcomm with a target price of $160. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Qualcomm options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

QCOM

Qualcomm's Options: A Look at What the Big Money is Thinking

B. Riley Securities analyst Dave Kang maintains AXT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXTI#NASDAQ">AXTI</a>) with a Buy and lowers the price target from $6 to $4.5.

AXTI

B. Riley Securities Maintains Buy on AXT, Lowers Price Target to $4.5

Natera's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTRA#NYSE">NTRA</a>) short percent of float has risen 7.64% since its last report. The company recently reported that it has 6.01 million shares sold short, which is 4.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 3.4 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Natera Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746201630_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Natera has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Natera's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Natera's peer group average for short interest as a percentage of float is 6.21%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

NTRA

Peering Into Natera's Recent Short Interest

Knife River Holding's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNF#NYSE">KNF</a>) short percent of float has risen 9.04% since its last report. The company recently reported that it has 2.57 million shares sold short, which is 5.91% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.29 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Knife River Holding Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746201625_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Knife River Holding has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Knife River Holding's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Knife River Holding's peer group average for short interest as a percentage of float is 3.48%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Looking Into Knife River Holding's Recent Short Interest

Cummins's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMI#NYSE">CMI</a>) short percent of float has fallen 7.61% since its last report. The company recently reported that it has 2.03 million shares sold short, which is 1.7% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.85 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Cummins Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746201620_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cummins has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Cummins's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Cummins's peer group average for short interest as a percentage of float is 6.09%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About Cummins?

Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) has outperformed the market over the past 10 years by 4.38% on an annualized basis producing an average annual return of 14.86%. Currently, Guidewire Software has a market capitalization of $17.03 billion. 
Buying $1000 In GWRE: If an investor had bought $1000 of GWRE stock 10 years ago, it would be worth $3,975.11 today based on a price of $203.00 for GWRE at the time of writing.
<h3>Guidewire Software's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746201619_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GWRE

Here's How Much You Would Have Made Owning Guidewire Software Stock In The Last 10 Years

B. Riley Securities analyst Naved Khan maintains Airbnb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABNB#NASDAQ">ABNB</a>) with a Neutral and lowers the price target from $145 to $140.

ABNB

B. Riley Securities Maintains Neutral on Airbnb, Lowers Price Target to $140

MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) shares have been steadily climbing over the past month, driven by continued momentum in its Bitcoin-centric strategy and recent<a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45157469/michael-saylor-considers-competition-copying-strategys-bitcoin-playbook-mutually-beneficial-the-more-companies-that-join-the-better-it-is"> earnings activity. </a>
What To Know: This week, the company reported first-quarter revenue of $111.07 million, falling slightly below analyst expectations, while posting a significant adjusted loss of $16.53 per share. 
Despite this, MicroStrategy&#8217;s Bitcoin holdings, now totaling 553,555 BTC, have helped reinforce investor confidence. Year-to-date, the firm has acquired over 15,000 Bitcoin at an average price of $92,737, funded primarily through its ongoing stock offerings.
Additionally, MicroStrategy raised its 2025 targets for both Bitcoin yield and dollar gains, aiming for a 25% yield and $15 billion in BTC-related returns. Meanwhile, Canaccord Genuity raised its price target on the stock from $409 to $464.
MSTR Price Action: Microstrategy shares were up 3.63% at $395.47 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard?new_user=False&amp;backend=google-oauth2">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="553" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02112355/Screenshot-2025-05-02-at-11.23.30-1024x553.png" alt="" class="wp-image-899432" style="width:466px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02112355/Screenshot-2025-05-02-at-11.23.30-1024x553.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02112355/Screenshot-2025-05-02-at-11.23.30-300x162.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02112355/Screenshot-2025-05-02-at-11.23.30-768x414.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/02112355/Screenshot-2025-05-02-at-11.23.30.png 1501w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45166673/trump-pressures-fed-after-solid-jobs-cooling-inflation-lower-rates-now">Trump Pressures Fed After Solid Jobs, Cooling Inflation: &#8216;Lower Its Rate!&#8217; (CORRECTED)</a></li>
</ul>
Photo by DCStockPhotography via Shutterstock.

Movers

MSTR

What's Going On With MicroStrategy Shares?

<a href="https://breakingdefense.com/2025/05/army-to-cancel-planned-robotic-combat-vehicle-award-pause-howitzer-competition-sources/">https://breakingdefense.com/2025/05/army-to-cancel-planned-robotic-combat-vehicle-award-pause-howitzer-competition-sources/</a>
&nbsp;
In early March, Breaking Defense <a href="https://breakingdefense.com/2025/03/army-taps-textrons-ripsaw-m3-for-robotic-combat-vehicle-program-sources-say/">first reported</a> that industry sources had been notified that Textron Systems&#39;s Ripsaw 3 had won the RCV competition and the service was preparing to ink a deal with the victors. But around that same time, Army leaders identified RCV as one program to cut as part of the 8 percent budget drill to realign funding toward higher priorities, the service official told Breaking Defense.

Contracts

"Army To Cancel Planned Robotic Combat Vehicle Award, Pause Howitzer Competition" - Breaking Defense

UBS analyst Nik Cremo maintains WEX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WEX#NYSE">WEX</a>) with a Neutral and lowers the price target from $172 to $138.

UBS Maintains Neutral on WEX, Lowers Price Target to $138

Wedbush analyst Scott Devitt maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Outperform and raises the price target from $225 to $235.

AMZN

Wedbush Maintains Outperform on Amazon.com, Raises Price Target to $235

Keefe, Bruyette &amp; Woods analyst Sanjay Sakhrani maintains Regional Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RM#NYSE">RM</a>) with a Market Perform and lowers the price target from $33 to $30.

Keefe, Bruyette & Woods Maintains Market Perform on Regional Management, Lowers Price Target to $30

UBS analyst Michael Goldsmith maintains Lineage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINE#NASDAQ">LINE</a>) with a Neutral and lowers the price target from $62 to $49.

LINE

UBS Maintains Neutral on Lineage, Lowers Price Target to $49

Keefe, Bruyette &amp; Woods analyst Bose George reiterates Radian Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDN#NYSE">RDN</a>) with a Outperform and raises the price target from $37 to $38.

Reiteration

Keefe, Bruyette & Woods Reiterates Outperform on Radian Group, Raises Price Target to $38

Wedbush analyst Matt Bryson maintains AXT (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXTI#NASDAQ">AXTI</a>) with a Outperform and lowers the price target from $4.5 to $4.25.

Wedbush Maintains Outperform on AXT, Lowers Price Target to $4.25

WIIM

SYK stock has given up its prior loss. Stryker shares were trading lower after the company cut its FY25 adjusted EPS guidance and Evercore ISI group lowered its price target on the stock from $400 to $390.

Keefe, Bruyette &amp; Woods analyst Jade Rahmani maintains NexPoint Real Estate (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NREF#NYSE">NREF</a>) with a Market Perform and lowers the price target from $15 to $14.5.

NREF

Keefe, Bruyette & Woods Maintains Market Perform on NexPoint Real Estate, Lowers Price Target to $14.5

Amazon.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) announced its first-quarter results on Thursday, beating analyst estimates on the top and bottom lines. Analysts' reactions<a href="https://www.benzinga.com/25/05/45157181/apple-amazon-reddit-strategy-block-why-these-5-stocks-are-on-investors-radars-today"> are pouring in.&nbsp;</a>
Q1 Details: Amazon reported<a href="https://www.benzinga.com/general/entertainment/25/05/45151230/amazon-q1-earnings-double-beat-q2-guidance-ceo-focuses-on-making-customers-lives-easier-and-better"> first-quarter </a>revenue of $155.7 billion, up 9% year-over-year, which beat a Street consensus estimate of $155.04 billion according to data <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0501">from Benzinga Pro.</a>
The company reported first-quarter earnings per share of $1.59, beating a Street consensus estimate of $1.36.
Read Next: <a href="https://www.benzinga.com/news/management/25/05/45140155/musk-shifts-focus-back-to-tesla-says-doge-will-endure-without-him-is-buddha-needed-for-buddhism?utm_source=articleShare">Musk Shifts Focus Back To Tesla, Says DOGE Will Endure Without Him: &#8216;Is Buddha Needed For Buddhism?&#8217;</a>
<h2 class="wp-block-heading">Expert Ideas:</h2>
JPMorgan analyst Doug Anmuth highlighted Amazon&#8217;s Q1 revenue and operating income which exceeded the high end of guidance, with no significant negative impact from macroeconomic or tariff issues. He also pointed to AWS margins that reached an all-time high.&nbsp;
<ul>
<li>JPMorgan maintained Amazon stock with an Overweight and raised the price target from $220 to $225.&nbsp;</li>
</ul>
Rosenblatt analyst Barton Crockett labelled Amazon's first-quarter as "on the steady side of OK," but flagged the potential for impacts from tariffs which "could start hitting soon."&nbsp;
<ul>
<li>Rosenblatt maintained a Buy rating on Amazon and raised the price target by $1 to $288.&nbsp;</li>
</ul>
Needham's Laura Martin highlighted AWS's backlog which rose about 20% year-over-year to $189 billion with big client wins that included Adobe, Uber and Nasdaq. The analyst also noted that Amazon has benefited from forward buying ahead of tariff implementation.
<ul>
<li>Needham maintained its Buy rating and $220 price target on Amazon shares.&nbsp;</li>
</ul>
RBC Captial Markets analyst Brad Erickson also highlighted the growth in AWS backlog and expects acceleration in the second half of the year.&nbsp;
"We come away marginally more constructive on the prospect for another go at the AWS acceleration story," Erickson said.
<ul>
<li>RBC Capital Markets maintained an Outperform rating, but lowered its price target from $235 to $230.&nbsp;</li>
</ul>
Read Next: <a href="https://www.benzinga.com/news/econ-s/25/04/45108426/as-growth-falters-sentiment-slips-economist-says-risks-to-the-economic-outlook-are-increasing?utm_source=articleShare">As Growth Falters, Sentiment Slips, Economist Says &#8216;Risks To The Economic Outlook Are Increasing&#8217;</a>
Telsey Advisory Group analyst Joseph Feldman emphasized the company's investments in grocery, pharmacy, AI, faster delivery and rural delivery as future drivers of revenue.&nbsp;
<ul>
<li>Telsey Advisory Group maintained an Outperform rating and $225 price target on Amazon.&nbsp;</li>
</ul>
Wedbush's Scott Devitt and Dan Ives said that AWS came in slightly below expectations, but noted that AI demand is strong. The analysts also pointed to forward buying ahead of tariffs and "underwhelming" Q2 guidance from the company, but said it is navigating the uncertainty well and delivering profits. 
<ul>
<li>Wedbush maintained Amazon with an Outperform and raised its price target from $225 to $235.&nbsp;</li>
</ul>
Benchmark analyst Daniel Kurnos said the third-party seller revenue and AWS misses raise questions about Amazon's China exposure.&nbsp;
<ul>
<li>Benchmark maintained a Buy rating and $260 price target on Amazon shares.&nbsp;</li>
</ul>
Other Amazon analyst updates:&nbsp;
<ul>
<li>WestPark Capital analyst Curtis Shauger maintained a Buy rating and $280 price target.&nbsp;</li>
<li>JMP Securities analyst Nicholas Jones maintained Amazon with an Outperform and raised the price target from $240 to $250.&nbsp;</li>
<li>Stifel analyst Mark Kelley reiterated a Buy rating, but lowered Amazon's price target from $248 to $245.&nbsp;</li>
<li>Cantor Fitzgerald analyst Deepak Mathivanan reiterated Amazon with an Overweight and raised the price target from $230 to $240.&nbsp;</li>
</ul>
AMZN Stock Price Action: Amazon shares were down 0.34% at $189.57 on Friday, according to data from Benzinga Pro.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/management/25/04/45084982/sofi-brings-crypto-back-after-trump-policy-changes?utm_source=articleShare">SoFi Brings Crypto Back After Trump Policy Changes&nbsp;</a></li>
</ul>
Image: Shutterstock

Analyst Color

Earnings

Large Cap

Tech

Amazon Delivers Q1 'On The Steady Side Of OK,' As Analysts Highlight AWS, AI Demand

Health Care

Press Releases

FDA Grants Fast Track Designation to CRB-701 for the Treatment of Relapsed or Refractory Metastatic Cervical Cancer

Corbus Pharmaceuticals Announces Dosing of First Patient in its First-In-Human Study of CRB-601 to Treat Patients with Advanced Solid Tumors

Corbus Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Corbus Pharmaceuticals Announces that Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at ASCO GU 2025

Corbus Pharmaceuticals to Present at the Guggenheim SMID Cap Biotech Conference

Corbus Pharmaceuticals Announces Clinical Data for CRB-701 from Western Dose Escalation Study to be Presented at 2025 ASCO-GU

CRB-701 (SYS6002) A Next Generation Nectin-4 Targeting ADC Demonstrates Encouraging Safety and Broader Efficacy in Phase 1 Study in the US and UK Presented at ASCO-GU 2025

Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences

Corbus Pharmaceuticals Reports Q4 and 2024 Financial Results and Provides a Corporate Update

General

Corbus Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Study of Next-Generation CB1 Inverse Agonist CRB-913 for the Treatment of Obesity

Comments

Corbus Pharmaceuticals

空売り

Corbus Pharmaceuticals (NASDAQ:CRBP) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル